Positive News SentimentPositive News P3 Health Partners Stock Price, News & Analysis (NASDAQ:PIII) $1.16 -0.04 (-2.92%) (As of 02:40 PM ET) Add Compare Share Share Today's Range$1.13▼$1.2050-Day Range$1.14▼$1.9052-Week Range$0.70▼$5.56Volume175,563 shsAverage Volume425,436 shsMarket Capitalization$364.75 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media P3 Health Partners MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside338.6% Upside$5.00 Price TargetShort InterestBearish7.20% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares$1 M Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.98) to ($0.54) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.97 out of 5 starsMedical Sector640th out of 949 stocksHealth Services Industry6th out of 12 stocks 3.3 Analyst's Opinion Consensus RatingP3 Health Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $5.00, P3 Health Partners has a forecasted upside of 338.6% from its current price of $1.14.Amount of Analyst CoverageP3 Health Partners has received no research coverage in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.20% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 7.3.Change versus previous monthShort interest in P3 Health Partners has recently increased by 0.86%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldP3 Health Partners does not currently pay a dividend.Dividend GrowthP3 Health Partners does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PIII. Previous Next 3.3 News and Social Media Coverage News SentimentP3 Health Partners has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.76 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for P3 Health Partners this week, compared to 0 articles on an average week.Search InterestOnly 1 people have searched for PIII on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, P3 Health Partners insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,002,600.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders17.06% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 23.57% of the stock of P3 Health Partners is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for P3 Health Partners are expected to grow in the coming year, from ($0.98) to ($0.54) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of P3 Health Partners is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of P3 Health Partners is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioP3 Health Partners has a P/B Ratio of 1.90. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About P3 Health Partners Stock (NASDAQ:PIII)P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.Read More PIII Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PIII Stock News HeadlinesNovember 15, 2023 | markets.businessinsider.comPositive Revenue Prospects and Improved Cash Flow: Reasons Behind David Larsen’s Buy Rating for P3 Health PartnersNovember 12, 2023 | finance.yahoo.comP3 Health Partners Inc. (NASDAQ:PIII) Q3 2023 Earnings Call TranscriptDecember 1, 2023 | Edge On The Street (Ad)Is Gold Really Boring?Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. November 8, 2023 | businesswire.com55,508November 8, 2023 | finance.yahoo.comP3 Health Partners Announces Third-Quarter and Year-to-Date 2023 ResultsNovember 3, 2023 | finance.yahoo.comP3 Health Partners Schedules Third-Quarter 2023 Earnings Release and Conference CallOctober 29, 2023 | finance.yahoo.comSeveral Insiders Invested In P3 Health Partners Flagging Positive NewsOctober 20, 2023 | money.usnews.comP3 Health Partners Inc - Ordinary Shares - Class ADecember 1, 2023 | Edge On The Street (Ad)Is Gold Really Boring?Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. October 6, 2023 | uk.investing.comP3 Health Partners Recent Insider ActivityOctober 4, 2023 | benzinga.comP3 Health Partners 10% Owner Trades $186K In Company StockOctober 4, 2023 | benzinga.comMassive Insider Trade At P3 Health PartnersSeptember 14, 2023 | finance.yahoo.comChicago Pacific Founders UGP III, LLC Buys 270,000 Shares of P3 Health Partners IncSeptember 12, 2023 | markets.businessinsider.comBTIG Keeps Their Buy Rating on P3 Health Partners (PIII)September 10, 2023 | seekingalpha.comP3 Health Partners: Right Place, Right Time, Wrong Horse To Back?September 1, 2023 | msn.comBTIG Initiates Coverage of P3 Health Partners Inc - (PIII) with Buy RecommendationAugust 8, 2023 | finance.yahoo.comAt US$2.14, Is P3 Health Partners Inc. (NASDAQ:PIII) Worth Looking At Closely?July 28, 2023 | finance.yahoo.comP3 Health Partners Schedules Second-Quarter 2023 Earnings Release and Conference CallJuly 19, 2023 | finance.yahoo.comA Look At The Fair Value Of P3 Health Partners Inc. (NASDAQ:PIII)July 10, 2023 | benzinga.comSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating P3 Health Partners Inc. for Potential Breaches of Fiduciary Duty By Its Board of DirectorsJuly 6, 2023 | msn.comP3 Health Partners Inc - (PIII) Price Target Decreased by 15.38% to 5.61June 15, 2023 | seekingalpha.comP3 Health Partners On Solid Path To ProfitabilityJune 9, 2023 | seekingalpha.comP3 Health Partners: Just Another SPAC-Listed 'Value-Based Care' Company?June 1, 2023 | msn.comWhy Shares of P3 Health Partners Soared This WeekMay 17, 2023 | benzinga.comChief Executive Officer At This Health Care Company Buys $284K of StockMay 17, 2023 | msn.comWhy P3 Healthcare Shares Jumped WednesdayMay 16, 2023 | finance.yahoo.comP3 Health Partners Inc. (NASDAQ:PIII) Q1 2023 Earnings Call TranscriptSee More Headlines Receive PIII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/08/2023Today12/01/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/29/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Health services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:PIII CUSIPN/A CIK1832511 Webforesightacq.com Phone702-910-3950FaxN/AEmployees600Year FoundedN/APrice Target and Rating Average Stock Price Target$5.00 High Stock Price Target$5.00 Low Stock Price Target$5.00 Potential Upside/Downside+316.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($2,260.6599) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-270,130,000.00 Net Margins-10.73% Pretax Margin-54.92% Return on Equity2,454.69% Return on Assets37.99% Debt Debt-to-Equity Ratio0.58 Current Ratio0.67 Quick Ratio0.67 Sales & Book Value Annual Sales$1.18 billion Price / Sales0.32 Cash Flow$40.00 per share Price / Cash Flow0.03 Book Value$0.60 per share Price / Book2.00Miscellaneous Outstanding Shares313,089,000Free Float259,676,000Market Cap$375.71 million OptionableNot Optionable Beta1.39 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Sherif Abdou F.A.C.E.P. (Age 62)FACP, M.D., Co-Founder, CEO & Director Comp: $7.1MDr. Amir Bacchus M.B.A. (Age 58)M.D., Co-Founder, Chief Medical Officer & Director Comp: $4.3MMr. Atul KavthekarCFO & Chief Accounting OfficerMr. William BettermannExecutive VP & COOMr. Devery GoodeySenior Vice President of TechnologyMs. Karen BlomquistVice President of Investor RelationsMs. Jessica PuathasnanonChief Legal Officer, General Counsel & SecretaryRoy YoungbloodDirector of ComplianceMs. Kassi Belz APRExecutive Vice President of Communications, Culture & EngagementMs. Lorie Glisson CPAFlorida Market PresidentMore ExecutivesKey CompetitorsSharecareNASDAQ:SHCRThe Pennant GroupNASDAQ:PNTGTalkspaceNASDAQ:TALKDocGoNASDAQ:DCGOInnovAgeNASDAQ:INNVView All CompetitorsInsiders & InstitutionsWalleye Trading LLCBought 27,036 shares on 11/21/2023Ownership: 0.012%Ameriprise Financial Inc.Bought 2,831,604 shares on 11/15/2023Ownership: 1.740%GSA Capital Partners LLPBought 99,446 shares on 11/15/2023Ownership: 0.032%Tower Research Capital LLC TRC Bought 34,096 shares on 11/14/2023Ownership: 0.014%PNC Financial Services Group Inc.Bought 68,694 shares on 11/13/2023Ownership: 0.022%View All Insider TransactionsView All Institutional Transactions PIII Stock Analysis - Frequently Asked Questions Should I buy or sell P3 Health Partners stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for P3 Health Partners in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" PIII shares. View PIII analyst ratings or view top-rated stocks. What is P3 Health Partners' stock price target for 2024? 2 Wall Street research analysts have issued twelve-month target prices for P3 Health Partners' shares. Their PIII share price targets range from $5.00 to $5.00. On average, they anticipate the company's stock price to reach $5.00 in the next year. This suggests a possible upside of 338.6% from the stock's current price. View analysts price targets for PIII or view top-rated stocks among Wall Street analysts. How have PIII shares performed in 2023? P3 Health Partners' stock was trading at $1.84 on January 1st, 2023. Since then, PIII stock has decreased by 38.0% and is now trading at $1.14. View the best growth stocks for 2023 here. When is P3 Health Partners' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024. View our PIII earnings forecast. How were P3 Health Partners' earnings last quarter? P3 Health Partners Inc. (NASDAQ:PIII) announced its quarterly earnings results on Wednesday, November, 8th. The company reported ($0.12) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.11. The firm earned $288.35 million during the quarter, compared to analysts' expectations of $286 million. P3 Health Partners had a negative net margin of 10.73% and a positive trailing twelve-month return on equity of 2,454.69%. Who are P3 Health Partners' major shareholders? P3 Health Partners' stock is owned by many different retail and institutional investors. Top institutional shareholders include Ameriprise Financial Inc. (1.74%), FMR LLC (0.76%), Emfo LLC (0.32%), GSA Capital Partners LLP (0.03%), Principal Financial Group Inc. (0.03%) and PNC Financial Services Group Inc. (0.02%). Insiders that own company stock include Atul Kavthekar, Michael Balkin, Pacific Founders Ugp Chicago, Pacific Founders Ugp I Chicago and Sherif Abdou. View institutional ownership trends. How do I buy shares of P3 Health Partners? Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:PIII) was last updated on 12/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.